An additional benefit from using the HRR approach lies in its demonstrated value in treating key components of metabolic syndrome, to include positive outcomes for fasting plasma glucose[37], HDL cholesterol[38-40], and insulin levels[41], and prevalence of type 2 diabetes mellitus[42]. This evidence concerns the gene INS and diabetes mellitus.